Cycled Phototherapy

Trial ID or NCT#

NCT03927833

Status

recruiting iconRECRUITING

Purpose

Cycled phototherapy (PT) is likely to increase survival over that with continuous PT among extremely premature infants (\< 750 g BW or \<27 weeks GA).

Official Title

Cycled Phototherapy: a Safer Effective Method to Control the Serum Bilirubin of Extremely Premature Infants?

Eligibility Criteria

Ages Eligible for Study: 22 Weeks to 27 Weeks
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Infants is inborn2. Infant is ≤ 750 grams at birth and/or \< 27 weeks gestation at birth by best OB estimate3. Infant is 12-36 hours of age.
Exclusion Criteria:
  1. 1. Unable to enroll infant by 36 hours of age2. Previous phototherapy3. Known hemolytic disease4. TSB reported as \>6.0 mg/dL before 12 hours age5. Major anomaly6. Overt nonbacterial infection7. Infant is likely to expire soon: Limiting or withdrawal of intensive care is being recommended to the parents, the parents are requesting withdrawal of care, or the pH is \< 6.80 or persistent bradycardia with hypoxemia for \>2h.

Contact us to find out if this trial is right for you.

Contact

M. Bethany Ball
723-5711